<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 3.1g -->
    <!-- Field: Doc-Info; Name: Source; Value: TDLP 06302011 10Q.xfr; Date: 2012/02/22T22:14:05 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://transdelpharma.com/role/DocumentAndEntityInformation" xlink:href="tdlp-20110630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:href="tdlp-20110630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="tdlp-20110630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="tdlp-20110630.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="tdlp-20110630.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="tdlp-20110630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/GoingConcern" xlink:href="tdlp-20110630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/BankruptcyPetetionAndAssetPurchaseAgreement" xlink:href="tdlp-20110630.xsd#BankruptcyPetetionAndAssetPurchaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/NotesPayable" xlink:href="tdlp-20110630.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/StockholdersEquity" xlink:href="tdlp-20110630.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/StockOptionPlan" xlink:href="tdlp-20110630.xsd#StockOptionPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/Warrants" xlink:href="tdlp-20110630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/GainOnForgivenessOfLiabilities" xlink:href="tdlp-20110630.xsd#GainOnForgivenessOfLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/CommitmentsAndContingencies" xlink:href="tdlp-20110630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://transdelpharma.com/role/SubsequentEvents" xlink:href="tdlp-20110630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/DocumentAndEntityInformation" xlink:title="0001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:title="0002 - Statement - Condensed Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="0004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="0005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="0006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/GoingConcern" xlink:title="0007 - Disclosure - GOING CONCERN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/BankruptcyPetetionAndAssetPurchaseAgreement" xlink:title="0008 - Disclosure - BANKRUPTCY PETETION AND ASSET PURCHASE AGREEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/NotesPayable" xlink:title="0009 - Disclosure - NOTES PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/StockholdersEquity" xlink:title="0010 - Disclosure - STOCKHOLDERS' EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/StockOptionPlan" xlink:title="0011 - Disclosure - STOCK OPTION PLAN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/Warrants" xlink:title="0012 - Disclosure - WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/GainOnForgivenessOfLiabilities" xlink:title="0013 - Disclosure - GAIN ON FORGIVENESS OF LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/CommitmentsAndContingencies" xlink:title="0014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://transdelpharma.com/role/SubsequentEvents" xlink:title="0015 - Disclosure - SUBSEQUENT EVENTS" />
</link:linkbase>
</XBRL>
